港股异动 | 昭衍新药(06127)一度跌超9% 预计上半年营收同比下降逾17.3% 生物资产价值变动令其扭亏
Last Update:
15 7 月, 2025
Our site uses cookies. By using this site, you agree to the Privacy Policy and Terms of Use.